×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
LOGC – contextlogic inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
LOGC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/5
04:10 pm
logc
ContextLogic Holdings Inc. Reports Fourth-Quarter and Fiscal Year 2025 Financial Results
Low
Report
ContextLogic Holdings Inc. Reports Fourth-Quarter and Fiscal Year 2025 Financial Results
2/26
04:45 pm
logc
ContextLogic Completes $907.5 Million Acquisition of US Salt, Marking Transformation into Business Ownership Platform
Low
Report
ContextLogic Completes $907.5 Million Acquisition of US Salt, Marking Transformation into Business Ownership Platform
1/22
09:05 am
logc
ContextLogic Advances US Salt Acquisition with Launch of Fully Backstopped $115 Million Rights Offering Priced at $8.00 per share
Low
Report
ContextLogic Advances US Salt Acquisition with Launch of Fully Backstopped $115 Million Rights Offering Priced at $8.00 per share
1/21
11:26 am
logc
ContextLogic: Why We Exited But Continue To Follow Closely [Seeking Alpha]
Neutral
Report
ContextLogic: Why We Exited But Continue To Follow Closely [Seeking Alpha]
1/2
12:47 pm
logc
ContextLogic Makes Its Move [Seeking Alpha]
Low
Report
ContextLogic Makes Its Move [Seeking Alpha]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/11
08:35 pm
logc
Form 4 ContextLogic Holdings For: Mar 09 Filed by: Bobbili Raja
Low
Report
Form 4 ContextLogic Holdings For: Mar 09 Filed by: Bobbili Raja
2/26
08:42 pm
logc
Form 4 ContextLogic Holdings For: Feb 26 Filed by: Bobbili Raja
Low
Report
Form 4 ContextLogic Holdings For: Feb 26 Filed by: Bobbili Raja
2/26
08:38 pm
logc
Form 4 ContextLogic Holdings For: Feb 26 Filed by: ABRAMS CAPITAL, LLC
Low
Report
Form 4 ContextLogic Holdings For: Feb 26 Filed by: ABRAMS CAPITAL, LLC
2/26
08:37 pm
logc
Form 4 ContextLogic Holdings For: Feb 26 Filed by: Abrams David C
Low
Report
Form 4 ContextLogic Holdings For: Feb 26 Filed by: Abrams David C
2/26
08:30 pm
logc
Form 3 ContextLogic Holdings For: Feb 26 Filed by: Bobbili Raja
Low
Report
Form 3 ContextLogic Holdings For: Feb 26 Filed by: Bobbili Raja
2/26
08:25 pm
logc
Form 3 ContextLogic Holdings For: Feb 26 Filed by: ABRAMS CAPITAL, LLC
Low
Report
Form 3 ContextLogic Holdings For: Feb 26 Filed by: ABRAMS CAPITAL, LLC
2/26
08:24 pm
logc
Form 3 ContextLogic Holdings For: Feb 26 Filed by: Abrams David C
Low
Report
Form 3 ContextLogic Holdings For: Feb 26 Filed by: Abrams David C
1/23
06:05 am
logc
Form EFFECT ContextLogic Holdings
Neutral
Report
Form EFFECT ContextLogic Holdings
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/17
LogicBio Therapeutics Inc (NASDAQ: LOGC) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $20.00 price target on the stock.
31.5%
2/11 EQUITY ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against LogicBio Therapeutics, Inc. – LOGC 14.6%
4/29 Form DEF 14A LogicBio Therapeutics, For: Jun 19 10.9%
2/18 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LogicBio Therapeutics, Inc. - LOGC 10.8%
3/18 EQUITY ALERT: ROSEN, NATIONAL TRIAL COUNSEL, Files First Securities Class Action Lawsuit Against LogicBio Therapeutics, Inc. – LOGC 9.6%
8/13 Q2/2019 6/30/2019 EPS -0.450 ZacksConsensus -0.410 ActVsEst (0.040) - Miss 8.0%
4/23 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LogicBio Therapeutics, Inc. - LOGC 6.1%
3/23 ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds LogicBio Therapeutics, Inc. Investors of Important Deadline in Securities Class Action Commenced by the Firm – LOGC 6.0%
6/27 Form 8-K LogicBio Therapeutics, For: Jun 25 4.8%
8/29 Form 4 LogicBio Therapeutics, For: Aug 27 Filed by: Wilton Thomas 4.4%
2/11 EQUITY ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against LogicBio Therapeutics, Inc. – LOGC 14.6%
4/29 Form DEF 14A LogicBio Therapeutics, For: Jun 19 10.9%
2/18 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LogicBio Therapeutics, Inc. - LOGC 10.8%
3/18 EQUITY ALERT: ROSEN, NATIONAL TRIAL COUNSEL, Files First Securities Class Action Lawsuit Against LogicBio Therapeutics, Inc. – LOGC 9.6%
8/13 Q2/2019 6/30/2019 EPS -0.450 ZacksConsensus -0.410 ActVsEst (0.040) - Miss 8.0%
4/23 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LogicBio Therapeutics, Inc. - LOGC 6.1%
3/23 ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds LogicBio Therapeutics, Inc. Investors of Important Deadline in Securities Class Action Commenced by the Firm – LOGC 6.0%
6/27 Form 8-K LogicBio Therapeutics, For: Jun 25 4.8%
8/29 Form 4 LogicBio Therapeutics, For: Aug 27 Filed by: Wilton Thomas 4.4%
TOP News Decliners
2/10
LogicBio Therapeutics Provides Update on FDA Review of Investigational New Drug Application for LB-001 for Methylmalonic Acidemia
-32.0%
8/13 Form 10-Q LogicBio Therapeutics, For: Jun 30 -15.7%
8/13 LogicBio up 20% ahead of IND filing for lead gene therapy candidate [Seeking Alpha] -11.9%
3/19 Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against LogicBio Therapeutics, Inc. (LOGC) -11.3%
3/27 LOGICBIO THERAPEUTICS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against LogicBio Therapeutics, Inc -11.2%
8/10 LogicBio Therapeutics Inc (NASDAQ: LOGC) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -10.7%
8/23 LogicBio Therapeutics Inc (NASDAQ: LOGC) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -10.2%
4/25 ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds LogicBio Therapeutics, Inc. Investors of the Important Deadline in Securities Class Action First Filed by Firm – LOGC -10.1%
2/21 LogicBio Therapeutics Inc (NASDAQ: LOGC) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -9.2%
6/24 Form 8-K LogicBio Therapeutics, For: Jun 24 -9.0%
8/13 Form 10-Q LogicBio Therapeutics, For: Jun 30 -15.7%
8/13 LogicBio up 20% ahead of IND filing for lead gene therapy candidate [Seeking Alpha] -11.9%
3/19 Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against LogicBio Therapeutics, Inc. (LOGC) -11.3%
3/27 LOGICBIO THERAPEUTICS, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the District of New Jersey against LogicBio Therapeutics, Inc -11.2%
8/10 LogicBio Therapeutics Inc (NASDAQ: LOGC) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -10.7%
8/23 LogicBio Therapeutics Inc (NASDAQ: LOGC) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -10.2%
4/25 ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Reminds LogicBio Therapeutics, Inc. Investors of the Important Deadline in Securities Class Action First Filed by Firm – LOGC -10.1%
2/21 LogicBio Therapeutics Inc (NASDAQ: LOGC) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating. -9.2%
6/24 Form 8-K LogicBio Therapeutics, For: Jun 24 -9.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: